CONTINUE TO SITE
OR WAIT 15 SECS
The Hunter Medical Research Institute (HMRI) has announced a new partnership with Novartis Australia, formalis
South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significan
A new breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-fr
Infinitus (China) Company has secured approval for its Sino-British Joint Laboratory on Health and Ageing proj
In a breakthrough for the advanced study of gut health, scientists at the National University of Singapore (NU
The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announce
XDENT LAB, one of the leading providers in the field of Removable Denture manufacturing in Vietnam, has offici
Smith+Nephew, the global medical technology company, has announced the launch of a comprehensive foot & an
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and s
Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys
APAC takes Centre stage in AI-Driven Drug Discovery
The Asia-Pacific (APAC) region is rapidly emerging as a leader in AI-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration. Substantial investments, cutting-edge technologies, and strategic partnerships are optimising drug development efficiency. As Artificial Intelligence (AI) has become more embedded into many facets of everyday life, it has become an indispensable part of the drug discovery landscape. 2024 was the year of reckoning when AI in drug discovery received the highest validation—three researchers who leveraged the neural network AI programme AlphaFold to predict protein structures won the Nobel Prize in Chemistry. The industry is pushing ahead, using tech to make the business of drug development faster, safer, and more economical. Morgan Stanley estimates that AI's use in drug development could lead to 50 more successful treatments over a decade, potentially creating a $50 billion market.
APAC takes centre-stage in AI-driven drug discovery
Accelerating Cancer Treatment with Precision Medicine & NGS
Malaysia Turns Key Med Tourism Hub
“Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly”
ISPOR 2025
ISPOR
info@ispor.org https://www.ispor.org/conferences-education/event/2025/05/13/default-calendar/ispor-2025Montreal
Liquid Biopsy for Precision Oncology Summit 2025
Hanson Wade
info@hansonwade.com https://hansonwade.com/precision-oncology-conferences/San Diego, USA
6th Glioblastoma Drug Development Summit 2025
Hanson Wade
info@hansonwade.com https://lbx-summit.com/Boston USA
